These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 7876548)
21. Expression of costimulatory molecules (CD80, CD86, CD28, CD152), accessory molecules (TCR alphabeta, TCR gammadelta) and T cell lineage molecules (CD4+, CD8+) in PBMC of leprosy patients using Mycobacterium leprae antigen (MLCWA) with murabutide and T cell peptide of Trat protein. Sridevi K; Neena K; Chitralekha KT; Arif AK; Tomar D; Rao DN Int Immunopharmacol; 2004 Jan; 4(1):1-14. PubMed ID: 14975355 [TBL] [Abstract][Full Text] [Related]
22. Cytokine patterns at the site of mycobacterial infection. Sieling PA; Modlin RL Immunobiology; 1994 Oct; 191(4-5):378-87. PubMed ID: 7713551 [TBL] [Abstract][Full Text] [Related]
23. Leprosy patients with lepromatous disease have an up-regulated IL-8 response that is unlinked to TNF-alpha responses. Hasan Z; Mahmood A; Zafar S; Khan AA; Hussain R Int J Lepr Other Mycobact Dis; 2004 Mar; 72(1):35-44. PubMed ID: 15217317 [TBL] [Abstract][Full Text] [Related]
24. Characterization of a novel high affinity human IL-7 receptor. Expression on T cells and association with IL-7 driven proliferation. Page TH; Willcocks JL; Taylor-Fishwick DA; Foxwell BM J Immunol; 1993 Nov; 151(9):4753-63. PubMed ID: 8409434 [TBL] [Abstract][Full Text] [Related]
25. A role for IL-12 receptor expression and signal transduction in host defense in leprosy. Kim J; Uyemura K; Van Dyke MK; Legaspi AJ; Rea TH; Shuai K; Modlin RL J Immunol; 2001 Jul; 167(2):779-86. PubMed ID: 11441083 [TBL] [Abstract][Full Text] [Related]
26. Differential interferon- gamma production characterizes the cytokine responses to Leishmania and Mycobacterium leprae antigens in concomitant mucocutaneous leishmaniasis and lepromatous leprosy. Matos DS; Azeredo-Coutinho RB; Schubach A; Conceição-Silva F; Baptista C; Moreira JS; Mendonça SC Clin Infect Dis; 2005 Jan; 40(2):e5-12. PubMed ID: 15655736 [TBL] [Abstract][Full Text] [Related]
27. IL-17 is produced by nickel-specific T lymphocytes and regulates ICAM-1 expression and chemokine production in human keratinocytes: synergistic or antagonist effects with IFN-gamma and TNF-alpha. Albanesi C; Cavani A; Girolomoni G J Immunol; 1999 Jan; 162(1):494-502. PubMed ID: 9886425 [TBL] [Abstract][Full Text] [Related]
28. A role for CD40-CD40 ligand interactions in the generation of type 1 cytokine responses in human leprosy. Yamauchi PS; Bleharski JR; Uyemura K; Kim J; Sieling PA; Miller A; Brightbill H; Schlienger K; Rea TH; Modlin RL J Immunol; 2000 Aug; 165(3):1506-12. PubMed ID: 10903757 [TBL] [Abstract][Full Text] [Related]
29. Humoral and cellular immune reactivity to recombinant M. leprae antigens in HLA-typed leprosy patients and healthy controls. Klatser PR; Janson AM; Thole JE; Buhrer S; Bos C; Soebono H; de Vries RR Int J Lepr Other Mycobact Dis; 1997 Jun; 65(2):178-89. PubMed ID: 9251589 [TBL] [Abstract][Full Text] [Related]
30. Immune profiling of leprosy and tuberculosis patients to 15-mer peptides of Mycobacterium leprae and M. tuberculosis GroES in a BCG vaccinated area: implications for development of vaccine and diagnostic reagents. Hussain R; Shahid F; Zafar S; Dojki M; Dockrell HM Immunology; 2004 Apr; 111(4):462-71. PubMed ID: 15056384 [TBL] [Abstract][Full Text] [Related]
31. Differential development of CD4 and CD8 cytotoxic T cells (CTL) in PBMC across the leprosy spectrum; IL-6 with IFN-gamma or IL-2 generate CTL in multibacillary patients. de la Barrera S; Finiasz DM; Fink S; Valdez R; Bottasso O; Balina LM; Sasiain MC Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):45-55. PubMed ID: 9207753 [TBL] [Abstract][Full Text] [Related]
32. Cytokine patterns of immunologically mediated tissue damage. Yamamura M; Wang XH; Ohmen JD; Uyemura K; Rea TH; Bloom BR; Modlin RL J Immunol; 1992 Aug; 149(4):1470-5. PubMed ID: 1500726 [TBL] [Abstract][Full Text] [Related]
33. Keratinocyte-derived T cell costimulation induces preferential production of IL-2 and IL-4 but not IFN-gamma. Goodman RE; Nestle F; Naidu YM; Green JM; Thompson CB; Nickoloff BJ; Turka LA J Immunol; 1994 Jun; 152(11):5189-98. PubMed ID: 7910619 [TBL] [Abstract][Full Text] [Related]
34. In vitro effect of interleukin-2 on proliferative responses of peripheral blood T cells from leprosy patients. Choi IH; Shin JS; Kim JD; Kim SJ Yonsei Med J; 1991 Sep; 32(3):237-42. PubMed ID: 1781183 [TBL] [Abstract][Full Text] [Related]
35. Evidence of cell-mediated immune contrasuppression in lepromatous leprosy: modulation of a putative T contrasuppressor cell-subset. González-Amaro R; Salazar-González JF; Baranda L; Abud-Mendoza C; Moncada B; García R; Alcocer-Varela J Clin Exp Immunol; 1988 Mar; 71(3):399-404. PubMed ID: 3133142 [TBL] [Abstract][Full Text] [Related]
36. A potential role for complement in immune evasion by Mycobacterium leprae. Callegaro-Filho D; Shrestha N; Burdick AE; Haslett PA J Drugs Dermatol; 2010 Nov; 9(11):1373-82. PubMed ID: 21061760 [TBL] [Abstract][Full Text] [Related]
37. Activation and regulation of Toll-like receptors 2 and 1 in human leprosy. Krutzik SR; Ochoa MT; Sieling PA; Uematsu S; Ng YW; Legaspi A; Liu PT; Cole ST; Godowski PJ; Maeda Y; Sarno EN; Norgard MV; Brennan PJ; Akira S; Rea TH; Modlin RL Nat Med; 2003 May; 9(5):525-32. PubMed ID: 12692544 [TBL] [Abstract][Full Text] [Related]
38. The role of interleukin-2 (IL-2) in the specific unresponsiveness of lepromatous leprosy to Mycobacterium leprae: studies in vitro and in vivo. Haregewoin A; Longley J; Bjune G; Mustafa AS; Godal T Immunol Lett; 1985; 11(3-4):249-52. PubMed ID: 3936783 [TBL] [Abstract][Full Text] [Related]
39. IL-12 up-regulates IL-18 receptor expression on T cells, Th1 cells, and B cells: synergism with IL-18 for IFN-gamma production. Yoshimoto T; Takeda K; Tanaka T; Ohkusu K; Kashiwamura S; Okamura H; Akira S; Nakanishi K J Immunol; 1998 Oct; 161(7):3400-7. PubMed ID: 9759857 [TBL] [Abstract][Full Text] [Related]